Search Results

There are 12483 results for: content related to: Chronic hepatitis C virus infection in renal transplant: treatment and outcome

  1. Ribavirin monotherapy for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Jesper Brok, Lise Lotte Gluud and Christian Gluud

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD005527.pub2

  2. You have free access to this content
    Synthesis and Evaluation of Bile Acid–Ribavirin Conjugates as Prodrugs to Target the Liver

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 9, September 2015, Pages: 2864–2876, Zhongqi Dong, Qing Li, Dong Guo, Yan Shu and James E. Polli

    Version of Record online : 2 FEB 2015, DOI: 10.1002/jps.24375

  3. You have free access to this content
    Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Goran Hauser, Tahany Awad, Jesper Brok, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk, Christian Gluud and Lise Lotte Gluud

    Published Online : 28 FEB 2014, DOI: 10.1002/14651858.CD005441.pub3

  4. Ribavirin in the treatment of chronic hepatitis C

    Journal of Gastroenterology and Hepatology

    Volume 23, Issue 6, June 2008, Pages: 844–855, Paul Martin and Donald M Jensen

    Version of Record online : 6 JUN 2008, DOI: 10.1111/j.1440-1746.2008.05398.x

  5. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  6. Ribavirin plus interferon versus interferon for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Jesper Brok, Lise Lotte Gluud and Christian Gluud

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD005445.pub2

  7. Hepatitis C

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt033

  8. You have free access to this content
    Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions

    British Journal of Clinical Pharmacology

    Volume 46, Issue 6, December 1998, Pages: 563–570, Salim Khakoo, Paul Glue, Leonie Grellier, Beverley Wells, Allan Bell, Clive Dash, Iain Murray-Lyon, David Lypnyj, Brian Flannery, Karen Walters and Geoffrey M Dusheiko

    Version of Record online : 4 JAN 2002, DOI: 10.1046/j.1365-2125.1998.00836.x

  9. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  10. You have full text access to this OnlineOpen article
    Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection

    Liver International

    Volume 37, Issue 1, January 2017, Pages: 5–18, Jordan J. Feld, Ira M. Jacobson, Mark S. Sulkowski, Fred Poordad, Fernando Tatsch and Jean-Michel Pawlotsky

    Version of Record online : 29 SEP 2016, DOI: 10.1111/liv.13212

  11. You have free access to this content
    Guidelines for the Management of Hepatitis C Virus Infection

    Hepatology Research

    Volume 43, Issue 1, January 2013, Pages: 1–34, Editors of the Drafting Committee for Hepatitis Management Guidelines: The Japan Society of Hepatology

    Version of Record online : 18 JAN 2013, DOI: 10.1111/hepr.12020

  12. Ascending Multiple-Dose Pharmacokinetics of Viramidine, a Prodrug of Ribavirin, in Adult Subjects With Compensated Hepatitis C Infection

    The Journal of Clinical Pharmacology

    Volume 45, Issue 3, March 2005, Pages: 275–285, Dr Sanjee Aora, Dr Christine Xu, Ms Alice Teng, Ms Janet Peterson, Dr Li-Tain Yeh, Dr Robert Gish, Dr Daryl Lau, Dr Stephen Rossi and Dr Chin-chung Lin

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270004270152

  13. Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus

    Intervention Review

    The Cochrane Library

    Alfonso Iorio, Emanuela Marchesini, Tahany Awad and Lise Lotte Gluud

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD004888.pub2

  14. You have free access to this content
    Diagnosis, management, and treatment of hepatitis C: An update

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1335–1374, Marc G. Ghany, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 2 DEC 2008, DOI: 10.1002/hep.22759

  15. You have free access to this content
    Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters

    British Journal of Pharmacology

    Volume 123, Issue 8, April 1998, Pages: 1587–1592, Simon M. Jarvis, James A. Thorn and Paul Glue

    Version of Record online : 10 FEB 2009, DOI: 10.1038/sj.bjp.0701775

  16. You have free access to this content
    Aminoadamantanes versus other antiviral drugs for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Mieke H Lamers, Mark Broekman, Joost PH Drenth and Christian Gluud

    Published Online : 17 JUN 2014, DOI: 10.1002/14651858.CD011132.pub2

  17. Pharmacokinetics and Safety of Viramidine, a Prodrug of Ribavirin, in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 44, Issue 3, March 2004, Pages: 265–275, Chin-Chung Lin, Lee Philips, Christine Xu and Li-Tain Yeh

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004262974

  18. Impact of ribavirin dose reduction on the efficacy of pegylated interferon plus ribavirin combination therapy for elderly patients infected with genotype 1b and high viral loads

    Hepatology Research

    Volume 41, Issue 7, July 2011, Pages: 626–634, Hiroshi Kohno, Hirotaka Kouno, Shiomi Aimitsu, Yasuyuki Aisaka, Mikiya Kitamoto, Hiroiku Kawakami and Kazuaki Chayama

    Version of Record online : 28 JUN 2011, DOI: 10.1111/j.1872-034X.2011.00811.x

  19. Impact of ribavirin priming on viral kinetics and treatment response in chronic hepatitis C genotype 1 infection

    Journal of Viral Hepatitis

    Volume 21, Issue 1, January 2014, Pages: 42–52, U. Mihm, M.-W. Welker, G. Teuber, H. Wedemeyer, T. Berg, C. Sarrazin, S. Böhm, U. Alshuth, E. Herrmann and S. Zeuzem

    Version of Record online : 21 JUN 2013, DOI: 10.1111/jvh.12124

  20. Effects of Silymarin, Glycyrrhizin, and Oxymatrine on the Pharmacokinetics of Ribavirin and Its Major Metabolite in Rats

    Phytotherapy Research

    Volume 30, Issue 4, April 2016, Pages: 618–626, Sha Liao, Xueyuan Jin, Jinglai Li, Tianhong Zhang, Wenpeng Zhang, Weiguo Shi, Shiyong Fan, Xiaoying Wang, Juan Wang, Bohua Zhong and Zhenqing Zhang

    Version of Record online : 22 JAN 2016, DOI: 10.1002/ptr.5567